A variety of patient, treatment, and pathologic factors are associated with an increased risk of ipsilateral breast tumor recurrence (local recurrence) after breast conservation therapy for invasive breast cancer. Arguably, the most important of these has been the status of the microscopic margins of excision of the resected breast specimen. Among patients treated with breast-conserving surgery and radiation therapy, positive margins (ie, invasive carcinoma or ductal carcinoma in situ [DCIS] touching an inked tissue edge) are associated with a 2-fold increase in the risk of local recurrence when compared with negative margins.1 Therefore, obtaining negative margins prior to radiation therapy is the primary goal of breast-conserving surgery, and minimizing the microscopic residual tumor burden through removal of larger amounts of normal breast tissue has traditionally been considered a major factor for optimizing local control.Although it has been more than 20 years since 6 randomized clinical trials reported that treatment with breast-conserving surgery and radiation therapy results in equivalent survival to mastectomy for women with earlystage breast cancer, there is still no universal agreement on what constitutes an adequate negative margin for patients being managed with the breast-conserving approach. Surveys of surgeons and radiation oncologists have demonstrated that there is no single threshold margin width identified as adequate by more than 50% of respondents. When 318 surgeons were presented with a scenario involving a patient with a T1 invasive breast cancer with planned radiation therapy following lumpectomy, 11% indicated that tumor not touching ink was an adequate negative margin, 42% favored a margin of at least 1 to 2 mm, 28% favored a margin of 5 mm or more, and 19% preferred a margin of more than 10 mm.2 In a survey of 730 surgeons in Canada, 40% considered a margin negative for invasive breast cancer if there was no tumor at ink, 14% required at least a 1-mm margin, 29% at least a 2-mm margin, and 18% at least a 5-mm margin. A similar pattern was seen for patients with DCIS.3 Finally, in a survey of 702 North American radiation oncologists, 45.9% considered a margin negative when there was no tumor at the inked margin; margin widths of 1, 2, 3, 5, and 10 mm were considered negative by 7.4%, 21.8%, 10%, 10%, and 4.9% of respondents, respectively. 4 Lack of consistency among clinicians in defining an adequate negative margin has led to wide variation in the rate of re-excision following lumpectomy. In a study that included 54 surgeons, rates of re-excision ranged from 0% to 70%.5 Moreover, approximately half of these re-excisions were performed in patients with negative margins, apparently with the belief that a wider negative margin would further decrease the rate of local recurrence.In current clinical practice, 10-year local recurrence rates after breast-conserving surgery and radiation therapy are low, ranging from 5% to 10%. For the most common subgroup of breast cancer patients, that is,...